Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US2307701092
Ticker CPIX
Company CUMBERLAND PHARMACEUTICALS
Currency $
Price
Aware Investor Index (AII) 0.0000
Recommendation STRONG SELL
P/E 73.17
ROE 2.18 %
Capitalization 101,993,209 $
Dividend Yield 0.00 %
P/S 2.48
AII Position 724
P/E Position 668
ROE Position 709
Capitalization Position 736
Dividend Yield Position 595
Sales 41,150,000 $
10-Year Average Earnings 1,393,900 $
Shares Outstanding 15,911,577
Equity 63,922,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country United States
CUMBERLAND PHARMACEUTICALS Investor Relations Web Site http://investor.shareholder.com/cpix/index.cfm







Sales:

YEAR MONTH AMOUNT
2017 12 41,150,000.00 $
2016 12 33,026,000.00 $
2015 12 33,519,000.00 $
2014 12 36,901,000.00 $
2013 12 32,027,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 -7,979,000.00 $
2016 12 -945,000.00 $
2015 12 731,000.00 $
2014 12 2,423,000.00 $
2013 12 -2,105,000.00 $
2012 12 5,842,000.00 $
2011 12 5,658,000.00 $
2010 12 2,457,000.00 $
2009 12 3,091,000.00 $
2008 12 4,766,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 63,922,000.00 $
2016 12 73,121,000.00 $
2015 12 76,820,000.00 $
2014 12 80,752,791.00 $
2013 12 79,292,000.00 $
2012 12 85,566,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 15,911,577
2016 12 16,236,525
2015 12 17,094,754
2014 12 17,899,632
2013 12 18,332,997
2012 12 19,787,537

 












Bloomberg News for CUMBERLAND PHARMACEUTICALS:



Google News for CUMBERLAND PHARMACEUTICALS:

Nasdaq - 2 days ago
Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss, Misses ...
Cumberland Pharmaceuticals (CPIX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.19.
Seeking Alpha - 2 days ago
Cumberland Pharmaceuticals, Inc. (CPIX) CEO AJ Kazimi on Q3 ...
Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) Q3 2018 Earnings Conference Call November 13, 2018 4:30 PM ET. Executives.
PRNewswire (press release)
Cumberland Pharmaceuticals beats by $0.20, misses on revenue
Cumberland Pharmaceuticals (NASDAQ:CPIX): Q3 Non-GAAP EPS of -$0.05 beats by $0.20; GAAP EPS of -$0.11 beats by $0.14. Revenue of ...
U.S. News & World Report
Cumberland Pharmaceuticals (CPIX) Confirms Acquisition of VIBATIV
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it has entered into a definitive agreement to acquire VIBATIV® from ...
Seeking Alpha - 3 days ago
Cumberland Pharmaceuticals (CPIX) Stock Rating Lowered by ...
Cumberland Pharmaceuticals (NASDAQ:CPIX) was downgraded by research analysts at TheStreet from a “c-” rating to a “d+” rating in a report ...
StreetInsider.com - 6 Nov 2018
Investors Zero in on Cumberland Pharmaceuticals Inc. (NASDAQ ...
Major market players are buzzing over Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) as their share price hit $7 at the end of the most ...
PR Newswire (press release)
Cumberland Pharmaceuticals (CPIX) Lowered by TheStreet
TheStreet cut shares of Cumberland Pharmaceuticals (NASDAQ:CPIX) from a c- rating to a d+ rating in a report released on Tuesday morning.
Nashville Business Journal
Cumberland Pharmaceuticals (CPIX) Lowered to D+ at TheStreet
TheStreet cut shares of Cumberland Pharmaceuticals (NASDAQ:CPIX) from a c- rating to a d+ rating in a research report sent to investors on ...
Nashville Post
Dimensional Fund Advisors LP Has $5.35 Million Position in ...
Dimensional Fund Advisors LP lowered its stake in shares of Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) by 1.2% during the 2nd ...
Fairfield Current - 1 day ago
Cumberland Pharmaceuticals (CPIX) Posts Earnings Results, Beats ...
Cumberland Pharmaceuticals (NASDAQ:CPIX) announced its quarterly earnings data on Tuesday. The specialty pharmaceutical company ...


Back